Sigma Planning’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$494K Sell
9,387
-2,862
-23% -$129K 0.01% 841
2026
Q2
$515K Buy
12,249
+1,395
+13% +$44.4K 0.01% 900
2026
Q1
$287K Buy
10,854
+42
+0.4% +$1.23K 0.01% 1072
2025
Q4
$313K Buy
10,812
+3,074
+40% +$92.3K 0.01% 1004
2025
Q3
$215K Buy
+7,738
New +$196K 0.01% 1188
2024
Q3
– Sell
-9,111
Closed -$214K – 1214
2024
Q2
$214K Sell
9,111
-1,757
-16% -$44.3K 0.01% 1061
2024
Q1
$313K Buy
+10,868
New +$327K 0.01% 943
2023
Q4
– Sell
-11,867
Closed -$331K – 856
2023
Q3
$331K Buy
11,867
+109
+0.9% +$3.56K 0.01% 884
2023
Q2
$401K Sell
11,758
-2,222
-16% -$69.8K 0.01% 827
2023
Q1
$420K Buy
13,980
+303
+2% +$9.39K 0.01% 875
2022
Q4
$386K Sell
13,677
-2,995
-18% -$95.1K 0.01% 872
2022
Q3
$548K Buy
16,672
+936
+6% +$34.4K 0.02% 695
2022
Q2
$496K Sell
15,736
-3,857
-20% -$135K 0.02% 752
2022
Q1
$900K Sell
19,593
-25,263
-56% -$1.2M 0.03% 582
2021
Q4
$2.75M Sell
44,856
-6,366
-12% -$440K 0.08% 264
2021
Q3
$3.83M Sell
51,222
-12,174
-19% -$1.02M 0.12% 194
2021
Q2
$5.86M Sell
63,396
-13,146
-17% -$1.12M 0.17% 124
2021
Q1
$6.79M Sell
76,542
-27,350
-26% -$2.71M 0.22% 103
2020
Q4
$9.7M Buy
103,892
+4,059
+4% +$323K 0.33% 63
2020
Q3
$6.36M Sell
99,833
-9,212
-8% -$540K 0.25% 78
2020
Q2
$5.69M Buy
109,045
+96,557
+773% +$4.14M 0.25% 79
2020
Q1
$391K Sell
12,488
-3,031
-20% -$101K 0.02% 563
2019
Q4
$520K Buy
15,519
+4,291
+38% +$136K 0.02% 586
2019
Q3
$331K Buy
11,228
+3,673
+49% +$119K 0.02% 724
2019
Q2
$260K Buy
+7,555
New +$242K 0.01% 800

Other funds holding ARKG

Sigma Planning's ARKG Position: Q3 2026 in Review

Sigma Planning reduced its ARK Genomic Revolution ETF (ARKG) stake by 23% in Q3 2026, selling an estimated $129K and leaving 9,387 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #841.

Sigma Planning first reported a position in ARKG in Q2 2019 and has held it in 25 quarters since. The position peaked at $9.7M in Q4 2020. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Sigma Planning held 9,387 shares of ARK Genomic Revolution ETF worth $494K as of Q3 2026.
  • Sigma Planning sold 2,862 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $129K.
  • ARK Genomic Revolution ETF made up 0.01% of Sigma Planning's portfolio in Q3 2026, its #841 holding.
  • Sigma Planning first reported a position in ARK Genomic Revolution ETF in Q2 2019 and has held it in 25 quarters since.
  • Sigma Planning's ARK Genomic Revolution ETF position peaked at $9.7M in Q4 2020.
  • 260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.